TrialAnnals of hematology2020

Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission.

Makoto Hirosawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.